Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CONMED CorpCNMD · Entity 4691 | EVP, STRAT & CORP DEVT | March 02, 2026 | March 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CONMED Corp
Report date March 02, 2026 · Filed March 18, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| RSUs (Restricted Stock Units)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2036-03-02 | Direct | 16,926 |
Reported balance
After 2026-03-02 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2026-03-02 · Grant · Acquired 16,926 · Balance 16,926 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year. F2: This Form 4/A is filed solely to correct the amount of RSUs granted. A special award of 7,644 shares was awarded in addition to the originally reported 9,282 shares for a total of 16,926 RSUs granted. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year.
F2: This Form 4/A is filed solely to correct the amount of RSUs granted. A special award of 7,644 shares was awarded in addition to the originally reported 9,282 shares for a total of 16,926 RSUs granted.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2026 Filed Mar 4, 2026 20:57 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 10,999 | $0.00 Strike: $45.79 | $0.00 |
DisclosureSEC source: 0000816956-26-000021 · form4.xml · derivative · entry 2 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,999 Underlying: Common Stock · 10,999 shares Expires 2036-03-02 F2 · derivative.exercise_date: The stock options were granted under CONMED Corporation Corporation's 2025 Long-Term Incentive Plan, with the stock options generally vesting in equal amounts over a four-year period with the first 25% of the stock options vesting one year after the grant date. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 20:57 UTC | CONMED Corp CNMD · Entity 4691 | GrantRSUs (Restricted Stock Units) · Derivative | 9,282 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000816956-26-000021 · form4.xml · derivative · entry 1 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,282 Underlying: Common Stock · 9,282 shares Expires 2036-03-02 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year. Read SEC document |
| March 02, 2026 Filed Mar 18, 2026 17:53 UTC Amendment | CONMED Corp CNMD · Entity 4691 | GrantRSUs (Restricted Stock Units) · Derivative | 16,926 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000816956-26-000031 · form4a.xml · derivative · entry 1 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,926 Underlying: Common Stock · 16,926 shares Expires 2036-03-02 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year. F2 · derivative.underlying_shares: This Form 4/A is filed solely to correct the amount of RSUs granted. A special award of 7,644 shares was awarded in addition to the originally reported 9,282 shares for a total of 16,926 RSUs granted. Read SEC document |
| March 14, 2025 Filed Mar 17, 2025 20:07 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionSARs (Stock Appreciation Rights) · Derivative | 4,500 | $0.00 Strike: $55.42 | $0.00 |
DisclosureSEC source: 0001127602-25-009658 · form4.xml · derivative · entry 3 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,500 shares Expires 2025-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| March 14, 2025 Filed Mar 17, 2025 20:07 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 4,316 | $58.83 | $253,910.28 |
DisclosureSEC source: 0001127602-25-009658 · form4.xml · nonDerivative · entry 2 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,896.635 Read SEC document |
| March 14, 2025 Filed Mar 17, 2025 20:07 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 4,500 | $55.42 | $249,390.00 |
DisclosureSEC source: 0001127602-25-009658 · form4.xml · nonDerivative · entry 1 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,212.635 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 20:35 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 26,127 | $0.00 Strike: $58.33 | $0.00 |
DisclosureSEC source: 0001127602-25-008266 · form4.xml · derivative · entry 1 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,127 Underlying: Common Stock · 26,127 shares Expires 2035-03-03 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:39 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 18,988 | $0.00 Strike: $79.95 | $0.00 |
DisclosureSEC source: 0001127602-24-008540 · form4.xml · derivative · entry 1 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,988 Underlying: Common Stock · 18,988 shares Expires 2034-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| June 09, 2023 Filed Jun 12, 2023 20:52 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 4,500 | $0.00 Strike: $55.42 | $0.00 |
DisclosureSEC source: 0001127602-23-018593 · form4.xml · derivative · entry 3 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,500 Underlying: Common Stock · 4,500 shares Expires 2025-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| June 09, 2023 Filed Jun 12, 2023 20:52 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 2,650 | $132.44 | $350,966.00 |
DisclosureSEC source: 0001127602-23-018593 · form4.xml · nonDerivative · entry 2 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,711 Read SEC document |
| June 09, 2023 Filed Jun 12, 2023 20:52 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 4,500 | $55.42 | $249,390.00 |
DisclosureSEC source: 0001127602-23-018593 · form4.xml · nonDerivative · entry 1 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,361 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 28, 2023 Filed May 2, 2023 23:48 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 2,442 | $0.00 Strike: $39.87 | $0.00 |
DisclosureSEC source: 0001127602-23-014144 · form4.xml · derivative · entry 3 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,442 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| April 28, 2023 Filed May 2, 2023 23:48 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 2,442 | $128.00 | $312,576.00 |
DisclosureSEC source: 0001127602-23-014144 · form4.xml · nonDerivative · entry 2 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,861 Read SEC document |
| April 28, 2023 Filed May 2, 2023 23:48 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 2,442 | $39.87 | $97,362.54 |
DisclosureSEC source: 0001127602-23-014144 · form4.xml · nonDerivative · entry 1 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,303 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 03, 2023 Filed Feb 7, 2024 02:46 UTC | CONMED Corp CNMD · Entity 4691 | OtherCommon Stock | 1.635 | $102.39 | $167.40 |
DisclosureSEC source: 0001127602-24-003608 · form5.xml · nonDerivative · entry 1 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,712.635 Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:23 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 15,159 | $0.00 Strike: $96.16 | $0.00 |
DisclosureSEC source: 0001127602-23-008932 · form4.xml · derivative · entry 1 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,159 Underlying: Common Stock · 15,159 shares Expires 2033-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:11 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 20,000 | $0.00 Strike: $144.55 | $0.00 |
DisclosureSEC source: 0001127602-22-008099 · form4.xml · derivative · entry 1 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2032-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:38 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 19,550 | $0.00 Strike: $122.55 | $0.00 |
DisclosureSEC source: 0001127602-21-009296 · form4.xml · derivative · entry 1 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,550 Underlying: Common Stock · 19,550 shares Expires 2031-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| October 30, 2020 Filed Oct 30, 2020 20:05 UTC | CONMED Corp CNMD · Entity 4691 | OtherSars (Stock Appreciation Rights) · Derivative | 11,000 | $55.42 Strike: $55.42 | $609,620.00 |
DisclosureSEC source: 0001127602-20-027714 · form4.xml · derivative · entry 6 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 11,000 shares Expires 2025-05-11 F1 · kind: Assignment of options to Mr. Shagory's former spouse as approved by Compensation Committee. F5 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| October 30, 2020 Filed Oct 30, 2020 20:05 UTC | CONMED Corp CNMD · Entity 4691 | OtherOptions To Purchase Common Stock · Derivative | 1,998 | $0.00 Strike: $39.87 | $0.00 |
DisclosureSEC source: 0001127602-20-027714 · form4.xml · derivative · entry 5 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,442 Underlying: Common Stock · 1,998 shares Expires 2026-03-01 F1 · kind: Assignment of options to Mr. Shagory's former spouse as approved by Compensation Committee. F3 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| October 30, 2020 Filed Oct 30, 2020 20:05 UTC | CONMED Corp CNMD · Entity 4691 | OtherOptions To Purchase Common Stock · Derivative | 11,960 | $0.00 Strike: $59.96 | $0.00 |
DisclosureSEC source: 0001127602-20-027714 · form4.xml · derivative · entry 4 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,040 Underlying: Common Stock · 11,960 shares Expires 2028-03-01 F1 · kind: Assignment of options to Mr. Shagory's former spouse as approved by Compensation Committee. F4 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| October 30, 2020 Filed Oct 30, 2020 20:05 UTC | CONMED Corp CNMD · Entity 4691 | OtherOptions To Purchase Common Stock · Derivative | 8,865 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-20-027714 · form4.xml · derivative · entry 3 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,435 Underlying: Common Stock · 8,865 shares Expires 2027-03-01 F1 · kind: Assignment of options to Mr. Shagory's former spouse as approved by Compensation Committee. F3 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| October 30, 2020 Filed Oct 30, 2020 20:05 UTC | CONMED Corp CNMD · Entity 4691 | OtherOptions To Purchase Common Stock · Derivative | 9,840 | $0.00 Strike: $78.76 | $0.00 |
DisclosureSEC source: 0001127602-20-027714 · form4.xml · derivative · entry 2 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,160 Underlying: Common Stock · 9,840 shares Expires 2029-03-01 F1 · kind: Assignment of options to Mr. Shagory's former spouse as approved by Compensation Committee. F2 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| October 30, 2020 Filed Oct 30, 2020 20:05 UTC | CONMED Corp CNMD · Entity 4691 | OtherOptions To Purchase Common Stock · Derivative | 8,050 | $0.00 Strike: $97.69 | $0.00 |
DisclosureSEC source: 0001127602-20-027714 · form4.xml · derivative · entry 1 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,950 Underlying: Common Stock · 8,050 shares Expires 2030-03-02 F1 · kind: Assignment of options to Mr. Shagory's former spouse as approved by Compensation Committee. F2 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| September 04, 2020 Filed Sep 8, 2020 18:39 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 4,200 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-20-024781 · form4.xml · derivative · entry 3 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,300 Underlying: Common Stock · 4,200 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| September 04, 2020 Filed Sep 8, 2020 18:39 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 4,200 | $85.88 | $360,696.00 |
DisclosureSEC source: 0001127602-20-024781 · form4.xml · nonDerivative · entry 2 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,861 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $85.87 to $85.99. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder. Read SEC document |
| September 04, 2020 Filed Sep 8, 2020 18:39 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 4,200 | $41.93 | $176,106.00 |
DisclosureSEC source: 0001127602-20-024781 · form4.xml · nonDerivative · entry 1 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,061 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2020 Filed Aug 3, 2020 21:13 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 4,440 | $0.00 Strike: $39.87 | $0.00 |
DisclosureSEC source: 0001127602-20-022573 · form4.xml · derivative · entry 3 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,440 Underlying: Common Stock · 4,440 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| July 31, 2020 Filed Aug 3, 2020 21:13 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 4,440 | $84.57 | $375,477.48 |
DisclosureSEC source: 0001127602-20-022573 · form4.xml · nonDerivative · entry 2 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,861 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.52 to $86.085. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder. Read SEC document |
| July 31, 2020 Filed Aug 3, 2020 21:13 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 4,440 | $39.87 | $177,022.80 |
DisclosureSEC source: 0001127602-20-022573 · form4.xml · nonDerivative · entry 1 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,301 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 21:50 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 23,000 | $0.00 Strike: $97.69 | $0.00 |
DisclosureSEC source: 0001127602-20-009066 · form4.xml · derivative · entry 4 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,000 Underlying: Common Stock · 23,000 shares Expires 2030-03-02 F2 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:50 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 300 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009066 · form4.xml · derivative · entry 3 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 300 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:50 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 88 | $94.64 | $8,328.32 |
DisclosureSEC source: 0001127602-20-009066 · form4.xml · nonDerivative · entry 2 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,861 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:50 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009066 · form4.xml · nonDerivative · entry 1 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2019 Filed Dec 16, 2019 20:00 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 1,500 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-19-035009 · form4.xml · derivative · entry 3 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 1,500 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| December 13, 2019 Filed Dec 16, 2019 20:00 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 1,500 | $111.02 | $166,530.00 |
DisclosureSEC source: 0001127602-19-035009 · form4.xml · nonDerivative · entry 2 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,649 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.01 to $111.04. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| December 13, 2019 Filed Dec 16, 2019 20:00 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 1,500 | $41.93 | $62,895.00 |
DisclosureSEC source: 0001127602-19-035009 · form4.xml · nonDerivative · entry 1 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,149 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 06, 2019 Filed Nov 7, 2019 22:00 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 1,820 | $0.00 Strike: $39.87 | $0.00 |
DisclosureSEC source: 0001127602-19-032218 · form4.xml · derivative · entry 3 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,880 Underlying: Common Stock · 1,820 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| November 06, 2019 Filed Nov 7, 2019 22:00 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 1,820 | $109.34 | $198,998.80 |
DisclosureSEC source: 0001127602-19-032218 · form4.xml · nonDerivative · entry 2 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,649 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.91 to $109.62. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| November 06, 2019 Filed Nov 7, 2019 22:00 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 1,820 | $39.87 | $72,563.40 |
DisclosureSEC source: 0001127602-19-032218 · form4.xml · nonDerivative · entry 1 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,469 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2019 Filed Aug 13, 2019 15:52 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 2,000 | $0.00 Strike: $39.87 | $0.00 |
DisclosureSEC source: 0001127602-19-026483 · form4.xml · derivative · entry 3 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,700 Underlying: Common Stock · 2,000 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| August 09, 2019 Filed Aug 13, 2019 15:52 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 2,000 | $95.31 | $190,620.00 |
DisclosureSEC source: 0001127602-19-026483 · form4.xml · nonDerivative · entry 2 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,649 Read SEC document |
| August 09, 2019 Filed Aug 13, 2019 15:52 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 2,000 | $39.87 | $79,740.00 |
DisclosureSEC source: 0001127602-19-026483 · form4.xml · nonDerivative · entry 1 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,649 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2019 Filed Mar 13, 2019 00:00 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 3,000 | $0.00 Strike: $39.87 | $0.00 |
DisclosureSEC source: 0000899243-19-007354 · doc4.xml · derivative · entry 4 SHAGORY PETER K · CIK 0001398627 · EVP,STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,700 Underlying: Common Stock · 3,000 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Options exercised pursuant to carve out in Lock-Up Agreement. F1 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 08, 2019 Filed Mar 13, 2019 00:00 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 2,200 | $77.77 | $171,089.60 |
DisclosureSEC source: 0000899243-19-007354 · doc4.xml · nonDerivative · entry 3 SHAGORY PETER K · CIK 0001398627 · EVP,STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,649 Read SEC document |
| March 08, 2019 Filed Mar 13, 2019 00:00 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 800 | $77.76 | $62,211.20 |
DisclosureSEC source: 0000899243-19-007354 · doc4.xml · nonDerivative · entry 2 SHAGORY PETER K · CIK 0001398627 · EVP,STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,849 Read SEC document |
| March 08, 2019 Filed Mar 13, 2019 00:00 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 3,000 | $39.87 | $119,610.00 |
DisclosureSEC source: 0000899243-19-007354 · doc4.xml · nonDerivative · entry 1 SHAGORY PETER K · CIK 0001398627 · EVP,STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,649 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:58 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 300 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-009965 · form4.xml · derivative · entry 7 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300 Underlying: Common Stock · 300 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:58 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 400 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-009965 · form4.xml · derivative · entry 6 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 400 shares Expires 2025-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:58 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 24,000 | $0.00 Strike: $78.76 | $0.00 |
DisclosureSEC source: 0001127602-19-009965 · form4.xml · derivative · entry 5 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2029-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.